All items in the Healthy Skepticism Library
All the 20111 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 183 of 202 pages ‹ First < 181 182 183 184 185 > Last ›
HSL4197
Kessler DA.
Drug promotion and scientific exchange. The role of the clinical investigator
N Engl J Med. 1991 Jul 18;325(3):201-3 1991 Jul 18;325:(3):201-3
HSL4228
Shimm DS, Spece RG Jr.
Industry reimbursement for entering patients into clinical trials: legal and ethical issues.
Ann Intern Med 1991 Jul 15;115:(2):148-51
HSL4283
Rennie D, Flanagin A, Glass RM.
Conflicts of interest in the publication of science
JAMA 1991 Jul 10;266:(2):266-267
HSL4275
Corpus JT.
Gifts to physicians from industry [5th of 5 letters]
JAMA 1991 Jul 3;266:(1):62-63
HSL4276
Goldstein AO.
Gifts to physicians from industry [1st of 5 letters]
JAMA 1991 Jul 3;266:(1):61
HSL4277
Leblond RF.
Gifts to physicians from industry [2nd of 5 letters]
JAMA 1991 Jul 3;266:(1):61-62
HSL4278
Leung AK, Robson WM.
Gifts to physicians from industry [3rd of 5 letters]
JAMA 1991 Jul 3;266:(1):62
HSL4279
McMurray RJ, Orentlicher D.
Gifts to physicians from industry [1st of 2 replies]
JAMA 1991 Jul 3;266:(1):63
HSL4281
Randall T.
Gifts to physicians from industry [2nd of 2 replies]
JAMA 1991 Jul 3;266:(1):63
HSL4282
Sanders JH.
Gifts to physicians from industry [4th of 5 letters]
JAMA 1991 Jul 3;266:(1):62
HSL4236
Terry PB.
Pulmonary physicians, principles, and pharmaceuticals.
Chest 1991 Jul;100:(1):223-6
HSL4274
Feisullin S, Sause RB.
Update on direct-to-consumer advertising of prescription drugs.
Am Pharm 1991 Jul;NS31:(7):47-52
HSL9458
American Academy of Pediatrics Committee on Drugs: Prescription drug advertising direct to the consumer.
Pediatrics. 1991 Jul;88:(1):174-5
HSL9472
Drea EJ, Groesch AA, Hester FG, Mutnick AH.
Clinical strategies in drug therapy selection: an application of "counter-detailing".
Top Hosp Pharm Manage 1991 Jul;11:(2):70-8
HSL9460
Conlan MF.
After the storm: has the scandal shaken your confidence?
Drug Topics 1991 Jun 17;135:40-42, 44
HSL9462
Conlan MF.
FDA eyes product ID code for all Rxs and OTCs
Drug Topics 1991 Jun 17;135:48
HSL4266
MaLAM Letter follow up—Can we tolerate Rhone Poulenc Rorer’s claims?
MaLAM Newsletter 1991 Jun
HSL4267
Re: the promotion of spiramycin
1991 Jun
HSL4268
Summary of correspondence July ’89—December ’90
MaLAM Newsletter 1991 Jun
HSL4269
Huston P.
Surviving in a get-tough-on promotion climate
Medical Marketing & Media 1991 Jun;26:(6):40-46, 48, 50-51
HSL4271
Sweeney HA.
Nothing has changed in 25 years
Medical Marketing & Media 1991 Jun;26:(6):42
HSL4272
Wolfe SM.
Promotional practices in the pharmaceutical industry
HAI News 1991 Jun;(59):1-2, 10-11
HSL4273
Re: the promotion of Polymagma
1991 Jun
HSL9469
Schwartz H.
Mail-order pharmacy squeezes drug prices
Pharmaceutical Executive 1991 Jun;11:20, 24, 27
HSL9471
Schwartz RM, Rifkin SM.
No more paper tiger
American Druggist 1991 Jun;203:26-27, 30, 32, 34
HSL9477
1990 Rise in prescription drug prices averages nearly 8%
American Journal of Hospital Pharmacy 1991 Jun;48:1122
HSL4190
Hillman AL, Eisenberg JM, Pauly MV, Bloom BS, Glick H, Kinosian B, Schwartz JS.
Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies.
N Engl J Med 1991 May 9;324:(19):1362-5
HSL4185
Goldstein JH.
Of mugs and marketing.
JAMA 1991 May 8;265:(18):2391-2
HSL4219
Rennie D.
Editors and advertisements? What responsibility do editors have for the advertisements in their journals
JAMA. 1991 May 08;265:(18):2394-6
HSL4264
Randall T.
AMA, pharmaceutical association form 'solid front' on gift-giving guidelines.
JAMA 1991 May 8;265:(18):2304-5
HSL4265
Randall T.
Not all drug firms subject to gifts guidelines, but, for physicians, their gifts are still taboo.
JAMA 1991 May 8;265:(18):2305
HSL5424
Lomas J, Enkin M, Anderson GM, Hannah WJ, Vayda E, Singer J.
Opinion leaders vs audit and feedback to implement practice guidelines Delivery after previous cesarean section.
JAMA 1991 May 1;265:(17):2202-7
HSL4263
Industry promotions: institutionalized deception
Drug Monitor 1991 May;6:(5):49-51
HSL9457
Sesti LM, Miles WA.
Concerning the case of: United States v American Pharmaceutical Association and Michigan State Pharmaceutical Association, Civil No G75-558 CA5, WD Michigan
Journal Michigan Pharmacist 1991 May;29:182-183
HSL9459
Dicello CA.
What pharmacy needs from industry to optimize pharmaceutical care
Pennsylvania Pharmacist 1991 May;72:17-18
HSL9474
Summers KH.
Managed health's impact on pharmacy practice
US-Pharmacist 1991 May;16:H16, H22-H24, H36
HSL9475
Davis JL, Madhavan S.
Should prescription drugs be advertised to consumers?
American Druggist 1991 May;203:82, 84-85
HSL9476
Schwartz RM.
ASCP to Pryor: where are our discounts?
American Druggist 1991 May;203:24, 26
HSL4180
Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR.
Publication bias in clinical research.
Lancet 1991 Apr 13;337:(8746):867-72
HSL4262
The world according to Ernest: the ethics of marketing drugs
The Economist 1991 Apr 668
HSL4203
Lexchin J.
PAAB: a lesson in self-government.
CMAJ 1991 Apr 1;144:(7):844-5
HSL4258
Re: the promotion of di-iodohydroxyquinolone
1991 Apr
HSL4259
Credibility and the marketing mix
1991 Apr
HSL4260
Griffin JP.
Who will fund postgraduate education after 1992?
J R Coll Physicians Lond 1991 Apr;25:(2):128
http://www.ncbi.nlm.nih.gov/pubmed/2066922
HSL4261
Everett SE.
Lay audience response to prescription drug advertising
Journal of Advertising Research 1991 Apr-May;31:43-49
HSL9467
Kirkpatrick MA.
Planning and executing a brown bag day
Pharmacy Times 1991 Apr;57:90, 93, 96, 98
HSL9468
Mail order prescription drug industry origins and growth
Pharmacy Business 1991 Apr;2:12, 21
HSL4257
Randall T.
New guidelines examine drug firm, CME relations.
JAMA 1991 Mar 20;265:(11):1354
HSL4256
Purvis A.
Cheaper can be better
Time 1991 Mar 1835
HSL4280
Randall T.
FDA scrutinizes 'off-label' promotions
JAMA 1991 Mar 7;266:(1):11
HSL4226
Scarpinato L.
Pharmaceutical representatives.
J Gen Intern Med 1991 Mar-Apr;6:(2):181
HSL4255
Re: the promotion of arginine asparate
1991 Mar
HSL9436
Joughin J.
Animal pharm
Pharmaceutical and Cosmetic Review 1991 Mar-Apr;18:28, 30
HSL9465
Blyth JS.
Pharmaceutical marketing in a new package
Pharmaceutical Executive 1991 Mar;11:86, 88
HSL9466
Huntsinger L.
How Medicaid's new drug legislation will affect Oregon's drug use review and prudent purchasing programs Part 2
Oregon Pharmacist 1991 Mar;39:8
HSL4209
Mick T.
Pharmaceutical funding and medical students.
JAMA 1991 Feb 6;265:(5):659,
HSL4254
Kleinerman MJ.
The hand that feeds.
JAMA 1991 Feb 6;265:(5):658,
HSL1774
Goodfriend TL.
Using pharmaceutical advertising in medical education.
Acad Med 1991 Feb;66:(2):122
HSL4178
Dominguez-Soto L, Geo Gonzalez M.
Advertising, pharmaceutical industry, and dermatology.
Int J Dermatol 1991 Feb;30:(2):149
HSL4200
Kopera H.
The pharmaceutical industry as a source of drug information.
Int J Clin Pharmacol Ther Toxicol 1991 Feb;29:(2):45-7
HSL4252
Re: the promotion of minocycline
1991 Feb
HSL4253
Greenwood J.
Organised interests and the internal market
1991 Feb;
HSL9470
Huntsinger L.
How Medicaid's new drug legislation will affect Oregon's drug use review and prudent purchasing programs Part 1
Oregon Pharmacist 1991 Feb;39:8
HSL4164
Gifts to physicians from industry.
JAMA. 1991 Jan 23-30;265:(4):501
HSL4211
Moser M, Blaufox MD, Freis E, Gifford RW Jr, Kirkendall W, Langford H, Shapiro A, Sheps S.
Who really determines your patients' prescriptions?
JAMA 1991 Jan 23-30;265:(4):498-500
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1985236&query_hl=45
HSL4215
Randall T.
Does advertising influence physicians?
JAMA 1991 Jan 23-30;265:(4):443
HSL4216
Randall T.
Ethics of receiving gifts considered.
JAMA 1991 Jan 23-30;265:(4):442-3
HSL4217
Randall T.
Kennedy hearings say no more free lunch--or much else--from drug firms.
JAMA 1991 Jan 23-30;265:(4):440,
HSL4241
Weerasuriya K.
IFPMA code on advertising.
Lancet 1991 Jan 19;337:(8734):178
HSL4204
Lexchin J.
A sample argument.
CMAJ 1991 Jan 15;144:(2):118-9
HSL9473
Conlan MF.
Drug firms spend $165 million a year to influence prescribers
Drug Topics 1991 Jan 7;135:44, 46, 48
HSL4250
Stern RS, Arndt KA, Baughman RB.
Consensus reports from the convinced: manipulating the information transfer process for drug promotion.
JAMA 1991 Jan 2;265:(1):30
HSL4193
Hume AL, Shaughnessy AF.
Sources of influence on the prescribing practices of residents in family medicine.
DICP 1991 Jan;25:(1):102-3
HSL4246
Legislation for the sake of legislation: the EC advertising proposal
Health Horizons 1991 Jan
www.ifpma.rog/hhhs/welcome.htm
HSL4247
MaLAM Letter follow up—Upjohn announce worldwide withdrawal of Kaomycin
MaLAM Newsletter 1991 Jan
HSL4248
Re: the promotion of oral streptokinase/streptodornase
1991 Jan
HSL4249
Summary of correspondence July ’89—June ’90
MaLAM Newsletter 1991 Jan
HSL9480
Leblang TR.
Expert witnesses
American Druggist 1991 Jan;203:51
HSL9493
Summary of 1990 Medicaid drug rebate legislation: ASHP Government Affairs Division.
Am J Hosp Pharm 1991 Jan;48:(1):114-7
HSL2109
Labossiere MC.
Fallacies: The Nizkor Project
1991
http://www.nizkor.org/features/fallacies/index.html
HSL2713
Lee PR, Lurie P, Silverman MM, Lydecker M.
Drug promotion and labeling in developing countries: an update.
J Clin Epidemiol 1991;44:
HSL3676
Masson A.
Direct-to-consumer advertising: a continuing controversy. Proceedings of the
Snowbird Utah: Direct-to-consumer advertising: a continuing controversy. Proceedings of the 1991
HSL4165
Ahmad SR.
Crackdown on misleading drug promotion
Lancet 1991;338:1384-1385
HSL4166
Anderson J, Felson DT, Meenan RF.
Secular changes in published clinical trials of second-line agents in rheumatoid arthritis
Arthritis and Rheumatism 1991;34:1304-1309
HSL4167
Arkinstall WW.
Medical ethics
Annals of the Royal College of Physicians and Surgeons of Canada 1991;24:161
HSL4168
Barrett J.
Cost-effectiveness in advertising
Lancet 1991;338:699-700
HSL4170
Boyer JG, Hirsch JD, Osterhaus JT, Townsend RJ.
Potential for bias in economic analyses
New England Journal of Medicine 1991;325:1385
HSL4171
Chan J, Einarson T.
Drug detailing in the hospital: background for policy development
Canadian Journal of Hospital Pharmacy 1991;44:161-166
HSL4172
Chepesiuk R.
CE sponsorship
Drug Merchandising 1991;72:(6):7
HSL4173
Chirac P.
Ethics in the pharmaceutical industry: acceptance of responsibility or a facet of marketing?
International Journal of Risk & Safety in Medcine 1991;2:7-10
HSL4174
Clairman A.
Junk mail reduction
Canadian Family Physician 1991;37:282
HSL4175
Clearwater G.
Advertising junk mail
New Zealand Medical Journal 1991;104:344
HSL4176
Cone M.
Activities of the International Federation of Pharmaceutical Manufacturers Associations in world health.
J Clin Epidemiol 1991;44:
HSL4177
Cutrer CM, Pleil AM.
Potential outcomes associated with direct-to-consumer advertising of prescription drugs: physicians’ perspectives
Journal of Pharmaceutical Marketing & Management 1991;5:(3-19):
HSL4179
Donaldson MS, Capron AM.
Potential for bias in economic analyses
New England Journal of Medicine 1991;325:1384-1385
HSL4181
Fevang L.
CPhA replies
Drug Merchandising 1991;72:(6):7, 9
HSL4182
Garattini S.
An end to the fun and games?
Lancet 1991;338:749-750
HSL4183
Gilgore LS.
A consideration of direct-to-consumer advertising of prescription drugs and potential legal problems with the brief summary requirement: Is the FDA's regulatory authority illusory?
Food Drug Cosmetic Law Journal 1991;46:849-859
HSL4184
Goihman-yahr M.
Editorial comment [response to Dominguez-Soto (1991)]
International Journal of Dermatology 1991;30:(2):149
HSL4186
Goldstein JH.
Doctoring medicine: reading between the lines of drug advertisements
Journal of Medical Humanities 1991;12:(2):73-83
Page 183 of 202 pages ‹ First < 181 182 183 184 185 > Last ›
